The Impact of Contact Lens Coefficient of Friction (CoF) on the Development of Lid Wiper Epitheliopathy (LWE)

NCT03209505 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-08-31

Study results available
· View outcomes & findings →

Summary

This study examines the development of Lid Wiper Epitheliopathy (LWE) in individuals fit with contact lenses having difference coefficients of friction (CoF)

Conditions

  • Lid Wiper Epitheliopathy

Interventions

DEVICE

Acuvue Oasys

FDA approved contact lens, fit for daily wear

DEVICE

Air Optix Night & Day Aqua

FDA approved contact lens, fit for daily wear

Sponsors & Collaborators

  • University of Houston

    lead OTHER

Principal Investigators

  • Eric R Ritchey, OD, PhD · University of Houston

  • Rachel Redfern, OD, PhD · University of Houston

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
46 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-26
Primary Completion
2018-04-13
Completion
2018-04-13
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03209505 on ClinicalTrials.gov